PTEN and metabolic dysfunction-associated steatohepatitis: Abnormal signaling in the PI3K/PTEN/AKT pathway contributes to the development of a variety of hepatic diseases, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), alcoholic liver disease (ALD), viral hepatitis and HCC [3].